Home
About Us
MedTech CellCentric has raised 90m in fresh funding.
The money will support the advancement of the Cambridge company's oral treatment for multiple myeloma, inobrodib.
The financing was co-led by RA Capital Management and new investor Forbion, with participation from Avego Bioscience Capital, as well as BrightEdge, the American Cancer Society's venture capital.
Selected Grant News Headlines
A customized collection of grant news from foundations and the federal government from around the Web.
Impact Investing News from...
Rockefeller Foundation
Boston Foundation
REDF
Russell Family Foundation
Weingart Foundation
Social Entrepreneurship
Spotlight
When it Comes to Social Enterprises, Failure is the Best Platform for Innovation
In the world of social enterprises, failure is a cringe-worthy moment nobody wants to talk about. But, social entrepreneurs can benefit from their failures.
